Table 4.

Risk of cancer in patients with Behçet disease according to years of followup with significantly increased specific cancers enlisted.

Yrs of FollowupObserved, nExpectedSIR95% CI
< 1Total: 8
3H: 2NHL, 1L
2B
2.962.701.26–5.13
1–3Total: 9
3B
11.130.810.39–1.48
4–6Total: 9
3B
1H: 1NHL
15.190.590.29–1.09
≥ 7Total: 49.570.420.13–1.01
  • Observed: newly diagnosed cancer cases of the BD cohort. Expected: cancer incidence (per 1000 person-yrs) × person-years of BD cohort ÷ 1000. H: hematological malignancy; NHL: non-Hodgkin lymphoma; L: leukemia; B: breast cancer.